These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

758 related items for PubMed ID: 19808194

  • 1. Results of trimodality therapy in patients with stage IIIA (N2-bulky) and stage IIIB non-small-cell lung cancer.
    Li J, Dai CH, Yu LC, Chen P, Li XQ, Shi SB, Wu JR.
    Clin Lung Cancer; 2009 Sep; 10(5):353-9. PubMed ID: 19808194
    [Abstract] [Full Text] [Related]

  • 2. Patterns of disease failure after trimodality therapy of nonsmall cell lung carcinoma pathologic stage IIIA (N2). Analysis of Cancer and Leukemia Group B Protocol 8935.
    Kumar P, Herndon J, Langer M, Kohman LJ, Elias AD, Kass FC, Eaton WL, Seagren SL, Green MR, Sugarbaker DJ.
    Cancer; 1996 Jun 01; 77(11):2393-9. PubMed ID: 8635112
    [Abstract] [Full Text] [Related]

  • 3. Phase II trial of a trimodality regimen for stage III non-small-cell lung cancer using chemotherapy as induction treatment with concurrent hyperfractionated chemoradiation with carboplatin and paclitaxel followed by subsequent resection: a single-center study.
    Friedel G, Budach W, Dippon J, Spengler W, Eschmann SM, Pfannenberg C, Al-Kamash F, Walles T, Aebert H, Kyriss T, Veit S, Kimmich M, Bamberg M, Kohlhaeufl M, Steger V, Hehr T.
    J Clin Oncol; 2010 Feb 20; 28(6):942-8. PubMed ID: 20100967
    [Abstract] [Full Text] [Related]

  • 4. A randomized trial comparing induction chemotherapy followed by surgery with surgery alone for patients with stage IIIA N2 non-small cell lung cancer (JCOG 9209).
    Nagai K, Tsuchiya R, Mori T, Tada H, Ichinose Y, Koike T, Kato H, Lung Cancer Surgical Study Group of the Japan Clinical Oncology Group.
    J Thorac Cardiovasc Surg; 2003 Feb 20; 125(2):254-60. PubMed ID: 12579093
    [Abstract] [Full Text] [Related]

  • 5. Accelerated induction therapy and resection for poor prognosis stage III non-small cell lung cancer.
    Rice TW, Adelstein DJ, Koka A, Tefft M, Kirby TJ, Van Kirk MA, Taylor ME, Olencki TE, Peereboom D, Budd GT.
    Ann Thorac Surg; 1995 Sep 20; 60(3):586-91; discussion 591-2. PubMed ID: 7677484
    [Abstract] [Full Text] [Related]

  • 6. Two commonly used neoadjuvant chemoradiotherapy regimens for locally advanced stage III non-small cell lung carcinoma: long-term results and associations with pathologic response.
    Machtay M, Lee JH, Stevenson JP, Shrager JB, Algazy KM, Treat J, Kaiser LR.
    J Thorac Cardiovasc Surg; 2004 Jan 20; 127(1):108-13. PubMed ID: 14752420
    [Abstract] [Full Text] [Related]

  • 7. Surgical resection of stage IIIA and stage IIIB non-small-cell lung cancer after concurrent induction chemoradiotherapy. A Southwest Oncology Group trial.
    Rusch VW, Albain KS, Crowley JJ, Rice TW, Lonchyna V, McKenna R, Livingston RB, Griffin BR, Benfield JR.
    J Thorac Cardiovasc Surg; 1993 Jan 20; 105(1):97-104; discussion 104-6. PubMed ID: 8380477
    [Abstract] [Full Text] [Related]

  • 8. Induction chemotherapy with mitomycin, vindesine, and cisplatin for stage IIIA (T1-3, N2) unresectable non-small-cell lung cancer: final results of the Toronto phase II trial.
    Burkes RL, Shepherd FA, Blackstein ME, Goldberg ME, Waters PF, Patterson GA, Todd T, Pearson FG, Jones D, Farooq S, McGlaughlin J, Ginsberg RJ.
    Lung Cancer; 2005 Jan 20; 47(1):103-9. PubMed ID: 15603860
    [Abstract] [Full Text] [Related]

  • 9. Twelve-year follow-up of trimodality therapy for stage IIIA non-small cell lung cancer.
    Weitberg AB, Liu L, Yashar J, Glicksman AS.
    J Exp Clin Cancer Res; 2001 Sep 20; 20(3):335-40. PubMed ID: 11718211
    [Abstract] [Full Text] [Related]

  • 10. Randomized controlled trial of resection versus radiotherapy after induction chemotherapy in stage IIIA-N2 non-small-cell lung cancer.
    van Meerbeeck JP, Kramer GW, Van Schil PE, Legrand C, Smit EF, Schramel F, Tjan-Heijnen VC, Biesma B, Debruyne C, van Zandwijk N, Splinter TA, Giaccone G, European Organisation for Research and Treatment of Cancer-Lung Cancer Group.
    J Natl Cancer Inst; 2007 Mar 21; 99(6):442-50. PubMed ID: 17374834
    [Abstract] [Full Text] [Related]

  • 11. Improved results of induction chemoradiation before surgical intervention for selected patients with stage IIIA-N2 non-small cell lung cancer.
    Uy KL, Darling G, Xu W, Yi QL, De Perrot M, Pierre AF, Waddell TK, Johnston MR, Bezjak A, Shepherd FA, Keshavjee S.
    J Thorac Cardiovasc Surg; 2007 Jul 21; 134(1):188-93. PubMed ID: 17599507
    [Abstract] [Full Text] [Related]

  • 12. Neoadjuvant chemoradiation with paclitaxel/carboplatin for selected Stage III non-small-cell lung cancer: long-term results of a trimodality Phase II protocol.
    Hehr T, Friedel G, Steger V, Spengler W, Eschmann SM, Bamberg M, Budach W.
    Int J Radiat Oncol Biol Phys; 2010 Apr 21; 76(5):1376-81. PubMed ID: 19864078
    [Abstract] [Full Text] [Related]

  • 13. Induction chemotherapy with triweekly docetaxel and cisplatin followed by concomitant chemoradiotherapy with or without surgery in stage III non-small-cell lung cancer: a phase II study.
    Aydiner A, Sen F, Saglam EK, Oral EN, Eralp Y, Tas F, Toker A, Dilege S.
    Clin Lung Cancer; 2011 Sep 21; 12(5):286-92. PubMed ID: 21729649
    [Abstract] [Full Text] [Related]

  • 14. Induction chemotherapy with and without recombinant human granulocyte colony-stimulating factor support in locally advanced stage IIIA/B non-small cell lung cancer.
    Fischer JR, Manegold C, Bülzebruck H, Vogt-Moykopf I, Drings P.
    Semin Oncol; 1994 Jun 21; 21(3 Suppl 4):20-7. PubMed ID: 7516094
    [Abstract] [Full Text] [Related]

  • 15. Concurrent cisplatin/etoposide plus 3D-conformal radiotherapy followed by surgery for stage IIB (superior sulcus T3N0)/III non-small cell lung cancer yields a high rate of pathological complete response.
    Pourel N, Santelmo N, Naafa N, Serre A, Hilgers W, Mineur L, Molinari N, Reboul F.
    Eur J Cardiothorac Surg; 2008 May 21; 33(5):829-36. PubMed ID: 18367406
    [Abstract] [Full Text] [Related]

  • 16. Long-term survival results for patients with locally advanced, initially unresectable non-small cell lung cancer treated with aggressive concurrent chemoradiation.
    Langer CJ, Curran WJ, Keller SM, Catalano RB, Litwin S, Blankstein KB, Haas N, Campli SN, Comis RL.
    Cancer J Sci Am; 1996 May 21; 2(2):99-105. PubMed ID: 9166507
    [Abstract] [Full Text] [Related]

  • 17. Pulmonary resection after curative intent radiotherapy (>59 Gy) and concurrent chemotherapy in non-small-cell lung cancer.
    Sonett JR, Suntharalingam M, Edelman MJ, Patel AB, Gamliel Z, Doyle A, Hausner P, Krasna M.
    Ann Thorac Surg; 2004 Oct 21; 78(4):1200-5; discussion 1206. PubMed ID: 15464470
    [Abstract] [Full Text] [Related]

  • 18. [Effect of preoperative chemotherapy for bulky N2 non-small-cell lung cancer].
    Togashi K, Sugawara M, Miyamura H, Sato Y, Tanabe Y, Kourakata H, Saito H, Sato K.
    Kyobu Geka; 1999 Oct 21; 52(11):915-9. PubMed ID: 10513156
    [Abstract] [Full Text] [Related]

  • 19. 10-year long-term survival (LTS) of induction chemotherapy with three cycles cisplatin/paclitaxel followed by concurrent chemoradiation cisplatin/etoposide/45 Gy (1.5 Gy bid) plus surgery in locally advanced non-small-cell lung cancer (NSCLC)-a multicenter phase-II trial (CISTAXOL).
    Eberhardt WE, Gauler TC, Lepechoux C, Stamatis G, Bildat S, Krbek T, Welter S, Grunenwald D, Fischer B, Rodrigo Hde L, Theegarten D, Le Chevalier T, Seeber S, Stuschke M, Poettgen C.
    Lung Cancer; 2013 Oct 21; 82(1):83-9. PubMed ID: 23957964
    [Abstract] [Full Text] [Related]

  • 20. A phase II trial of preoperative concurrent radiation therapy and weekly paclitaxel/carboplatin for patients with locally advanced non-small-cell lung cancer.
    Hainsworth JD, Gray JR, Litchy S, Bearden JD, Shaffer DW, Houston GA, Greco FA.
    Clin Lung Cancer; 2004 Jul 21; 6(1):33-42. PubMed ID: 15310415
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 38.